Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer

San Francisco, CA – September 16, 2024 – Ray Therapeutics, a leading optogenetics company, announced today the appointment of Christopher Whitmore as Chief Financial Officer. Mr. Whitmore is a highly accomplished executive who brings over 20 years of strategic finance, accounting, and operational expertise. His deep experience spans from early-stage biotech to publicly-traded companies, with […]